P3 Health PartnersPIII -9.50%47 EBITDA Margin % is 7.73% as of Mar. 2026. GuruFocus rates PIII with a GF Score™ of 47/100 and a GF Value™ of $9.22 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 664 Healthcare Providers & Services companies, P3 Health Partners ranks worse than 81.33% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. P3 Health Partners's EBITDA for the
three
months ended in Mar. 2026 was $30 Mil. P3 Health Partners's Revenue for the
three
months ended in Mar. 2026 was $386 Mil. Therefore, P3 Health Partners's EBITDA margin for the quarter that ended in Mar. 2026 was 7.73%.
P3 Health Partners (NAS:PIII) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
P3 Health Partners EBITDA Margin % Related Terms
P3 Health Partners EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for P3 Health Partners's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PIII vs EHSI, CDIX, DCGO: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, P3 Health Partners's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
P3 Health Partners EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, P3 Health Partners's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where P3 Health Partners's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
P3 Health Partners (PIII) has a EBITDA Margin % of 7.73% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on P3 Health Partners and its competitors. According to the industry distribution chart, P3 Health Partners ranks #540 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 81.3%.
Is P3 Health Partners' EBITDA Margin % too high?
P3 Health Partners' current EBITDA Margin % is 7.73%. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. P3 Health Partners' value of 7.73% is 24.3% below this industry median. Based on the distribution chart, P3 Health Partners ranks #540 out of 664 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, P3 Health Partners has a GF Score™ of 47/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does P3 Health Partners' EBITDA Margin % compare to EHSI and CDIX?
According to the Healthcare Providers & Services industry distribution chart, P3 Health Partners ranks #540 out of 664 companies for EBITDA Margin %. This places P3 Health Partners in the lower half of its industry. The industry median EBITDA Margin % is 10.21. P3 Health Partners' value of 7.73% is 24.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. P3 Health Partners's current EBITDA Margin % of 7.73% is 24.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on P3 Health Partners and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. P3 Health Partners's current EBITDA Margin % is 7.73%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is P3 Health Partners stock overvalued right now?
Based on GuruFocus' analysis, P3 Health Partners (PIII) is currently considered Modestly Overvalued. The stock's GF Value™ is $9.22, compared to a current price of $10.28 — trading 11.5% above its estimated fair value. The current EBITDA Margin % is 7.73% and 24.3% below the Healthcare Providers & Services industry median of 10.21. P3 Health Partners' overall GF Score™ is 47/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For P3 Health Partners (PIII), the current EBITDA Margin % is 7.73% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is P3 Health Partners (PIII) Overvalued in 2026?
Based on GuruFocus' analysis, P3 Health Partners stock appears to be overvalued.
The current stock price of $10.28 is trading 11.5% above its estimated GF Value™ of $9.22.
GuruFocus considers P3 Health Partners to be Modestly Overvalued.
Key valuation signals for PIII:
EBITDA Margin %: 7.73%
GF Value™: $9.22 vs. price of $10.28 (11.5% above fair value)
Industry Position: 24.3% below the Healthcare Providers & Services median (#540 of 664)
No single metric tells the full story. See the PIII stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all. It includes utilization management, care management, disease education, and maintenance of a quality improvement and quality management program for members assigned to the Company. The Company is also responsible for the credentialing of its providers, processing and payment of claims, and the establishment of a provider network for certain health plans.
47GF Score
Get the complete analysis for PIII
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PIII has been successfully added to your 
